QC
SLS icon

Quadrature Capital’s SELLAS Life Sciences SLS Stock Holding History

Quadrature Capital’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-16,579
Closed -$26.6K – 1620
2025
Q3 		$26.6K Sell
16,579
-7,705
-32% -$13.7K ﹤0.01% 984
2025
Q2 		$52.7K Buy
24,284
+3,611
+17% +$5.54K ﹤0.01% 942
2025
Q1 		$22.2K Buy
+20,673
New +$24.5K ﹤0.01% 1026

Other funds holding SLS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Quadrature Capital's SLS Position: Q4 2025 in Review

Quadrature Capital sold out of SELLAS Life Sciences (SLS) in Q4 2025, closing a stake of 16,579 shares — an estimated $26.6K sold.

Quadrature Capital first reported a position in SLS in Q1 2025 and held it in 3 quarters. The position peaked at $52.7K in Q2 2025. 112 funds tracked by Wall St. Rank hold SLS as of Q4 2025.

  • Quadrature Capital reported no remaining SELLAS Life Sciences position as of Q4 2025 after selling out during the quarter.
  • Quadrature Capital sold 16,579 SELLAS Life Sciences shares in Q4 2025, an estimated $26.6K.
  • Quadrature Capital first reported a position in SELLAS Life Sciences in Q1 2025 and held it in 3 quarters.
  • Quadrature Capital's SELLAS Life Sciences position peaked at $52.7K in Q2 2025.
  • 112 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q4 2025.

Based on Quadrature Capital's 13F filing for Q4 2025, filed 17 Feb 2026.